Venous thromboembolism, though rare in the community, is a major cause of death among hospitalized patients. It is estimated to cause 100,000 deaths per year and to contribute to mortality in another ...

The post-operative risk period for venous thromboembolism is still unknown and indications for post-discharge prophylaxis are controversial. Detectable thrombus formation after hip arthroplasty is ...

The majority of fatal cases of pulmonary embolism in hospitalized patients occur in acutely ill, medically treated patients. Current guidelines, based on a large number of prospective, randomized, ...

The patent’s assignee is Continuous Motionflow, Llc. News editors obtained the following quote from the background information supplied by the inventors: “It is estimated that more than a million ...

Functional impairment (FI) after hematopoietic cell transplantation (HCT) and impact on quality of life (QOL). Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind ...

ORLANDO, Fla. — Patients who underwent hip fracture surgery and were prescribed deep vein thrombosis prophylaxis for 28 days or more had a 67% lower chance of death and significantly lower ...

Bristol-Myers Squibb and Pfizer announced that the FDA has accepted for review a supplemental New Drug Application (sNDA) for Eliquis (apixaban), for prophylaxis of deep vein thrombosis (DVT), which ...

antithrombin III [human] Thrombate III inj Hereditary antithrombin III (AT-III) deficiency in surgical or obstetrical procedures and thromboembolism Infuse over 10–20mins. Dose (units required) = ...